Investigating the role of exosomes in brain diseases using brain organoids

Exploring exosomes in neurodevelopmental and neuropsychiatric diseases using brain organoids

NIH-funded research Weill Medical Coll of Cornell Univ · NIH-10741385

This study is looking at tiny particles called exosomes that help brain cells talk to each other, to see how they might be linked to conditions like Autism and Alzheimer's, using small lab-grown brain models to compare healthy brains with those affected by these disorders.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10741385 on NIH RePORTER

What this research studies

This research focuses on understanding how exosomes, which are tiny vesicles that facilitate communication between brain cells, may be involved in neurodevelopmental and neuropsychiatric diseases. By using brain organoids, which are lab-grown miniaturized versions of the brain, researchers will analyze the content and quantity of exosomes from both healthy individuals and those with conditions like Autism Spectrum Disorder and Alzheimer's Disease. The study aims to uncover how changes in exosome signaling could contribute to these disorders, potentially leading to new insights into their mechanisms and treatments.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Autism Spectrum Disorder or Alzheimer's Disease.

Not a fit: Patients with neurodevelopmental or psychiatric disorders not related to exosome signaling may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new diagnostic tools or therapies for neurodevelopmental and neuropsychiatric diseases.

How similar studies have performed: While the role of exosomes in neurodegenerative diseases has been studied, this specific approach using brain organoids to explore their impact on mental disorders is relatively novel.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.